Spectrum receives US FDA approval for Levoleucovorin for injection
Tuesday, April 29, 2008 14:00 IST Irvine, California
Spectrum Pharmaceuticals, Inc. has received marketing approval from the US Food and Drug Administration (FDA) for Levoleucovorin for Injection. It is indicated after high-dose methotrexate therapy in patients with osteosarcoma